Abstract: Provided are a deoxynucleoside modified ruthenium complex, and a preparation method and use thereof, The deoxynucleoside modified ruthenium complex has a structure represented by Formula I, wherein R represents one selected from the group consisting of trifluoromethyl, C1-6 alkyl, alkoxy, halogen, styryl, and nitro-substituted styryl.

Abstract: For example, a method includes collecting orientation data from a mobile device as a user of the mobile device moves within an indoor space, generating orientation estimates for the mobile device from the orientation data, generating distance estimates representing distances of the mobile device to a wireless access point in the indoor space, storing the orientation estimates and the distance estimates together as a series of data blocks, constructing a plurality of trajectory segments from the orientation estimates, identifying identifiers for a last number of trajectory segments, using data blocks corresponding to the last number of trajectory segments, and identifying a predicted place within the indoor space to which the user is expected to go by using the identifiers to traverse a prediction tree, where branches of the prediction tree that are associated with the identifiers define a path that ends at a leaf node corresponding to the predicted place.

Abstract: An APFC converter control method includes: obtaining an output voltage, an input voltage and an inductor current of the APFC converter; obtaining a voltage adjustment value according to a voltage error value between a preset reference voltage and the output voltage; obtaining a reference current according to the voltage adjustment value and the input voltage; obtaining a current error value according to the reference current and the inductor current; obtaining an adjustment coefficient of the proportional integration parameter; adjusting an integration parameter and a proportional parameter according to the adjustment coefficient; calculating an output control value according to the integration parameter, the proportional parameter and the current error value; and comparing the control value with sawtooth harmonics to adjust the duty cycle and to output a PWM signal.

Abstract: An architecture related to the creation of, and attribution to, experiences based on location, popularity, captured media, and/or objects. A method can comprise receiving social media data associated with a user associated with a user identity, generating an attributable identity token based on the social media data and a learning model, wherein the attributable identity token is associated with the user identity and is representative of location data and experience data, and wherein the learning model comprises a collection of rules, and disseminating, by the device, the attributable identity token to a group of user identities associated with a social media operator entity.

Abstract: Tasks associated with users can be managed for efficient workflow management. A task management component (TMC) can analyze, including performing artificial intelligence-based analysis on, task-related information relating to associated with a user(s), assessment information relating to assessing performance or expertise associated with a task, biometric information relating to health, diet, and activity associated with the user(s), and/or user(s) feedback information. Based on the analysis, TMC can adaptively adjust respective attributes associated with respective tasks, resulting in respective adjusted attributes associated with the respective tasks. Based on the respective adjusted attributes, TMC can determine task information and can present the task information to a device(s) associated with the user(s) to facilitate performance of the tasks.

Abstract: Creating scent models and using scent models in cross-reality environments can include capturing experience data identifying a scent detected and a context in which the scent was detected. The experience data can be provided to a scent modeling service to generate a scent model that can represent perceived scents and perceived scent intensities for a user. The scent model can be used to generate cross-reality session data to be used in a cross-reality session presented by a cross-reality device. The cross-reality device can include a scent generator and can generate the cross-reality session using data obtained from the user device. The cross-reality device can generate a further scent during the cross-reality session based on the scent model.

Abstract: The present disclosure provides an AS1411 oligonucleotide composite ruthenium complex nanoprobe, and a preparation method and use thereof, and belongs to the technical field of nanoprobes. In the present disclosure, the AS1411 oligonucleotide having the G-quadruplex conformation has a stable structure and can specifically bind with a nucleolin on the membrane of a tumor cell; and RuPEP, the ruthenium complex having the structure of formula 1, has excellent luminescence performance and can be used as a phosphorescent probe to highlight the tumor cell. The AS1411 oligonucleotide composite ruthenium complex nanoprobe provided by the present disclosure has a good property of entering a cancer cell, and can be used as a cancer diagnosis reagent to selectively identify and activate the transportation of an NCL receptor on a surface of the cancer cell to a nucleus, thereby promoting the imaging of the cancer cell.

Abstract: A virtual view drawing method, a rendering method and apparatus, and a decoding method are provided. A first visibility map and a first texture map of a target view are generated. Region segmentation is performed on the first texture map to obtain a region segmentation result. A parameter representing segmentation performance is determined according to the region segmentation result. Region re-segmentation is performed on the first texture map when the parameter representing segmentation performance does not satisfy a first condition, to obtain a final region segmentation of the first texture map. Pixels to-be-updated in a region in the first visibility map are updated according to the final region segmentation result of the first texture map, to obtain a second visibility map. The second visibility map is shaded to obtain a second texture map of the target view.

Abstract: An orthopedic surgical robot system; the orthopedic surgical robot system comprises: a robotic arm (10), a distal end (170) of the robotic arm (10) being used for providing a locked working point (O) for the orthopedic surgical robot system; a multi-link mechanism (20), wherein the multi-link mechanism (20) comprises: a first link (210), the first link (210) being coupled to the distal end (170) of the robotic arm (10); and a second link (220), a proximal end of the second link (220) being connected to the first link (210) in a movable manner, so that the movement of the second link (220) relative to the first link (210) provides the orthopedic surgical robot system with a locked working plane relative to the locked working point (O); a bone saw (30), the bone saw being coupled to the distal end of the second link (220) and operable in the locked working plane; and a control system (40), the control system (40) being coupled to the robotic arm (10), and controlling, on the basis of a basic control amount of t

Abstract: Some embodiments provide a method of identifying packet latency in a software defined datacenter (SDDC) that includes a network and multiple host computers executing multiple machines. At a first host computer, the method identifies and stores (i) multiple time values associated with several packet processing operations performed on a particular packet sent by a first machine executing on the first host computer, and (ii) a time value associated with packet transmission through the SDDC network from the first host computer to a second host computer that is a destination of the particular packet. The method provides the stored time values to a set of one or more controllers to process to identify multiple latencies experienced by multiple packets processed in the SDDC.

Abstract: Provided are novel fully human monoclonal antibodies that bind to human LAG-3. It also provides the methods of hybridoma generation using humanized rats, the nucleic acid molecules encoding the anti-LAG-3 antibodies, expression vectors and host cells used for the expression of anti-LAG-3 antibodies. The invention further provides the methods for validating the function of antibodies in vitro. The antibodies of invention provide a potent agent for the treatment of multiple cancers via modulating human immune function.

Abstract: The present application discloses a transport vehicle and a method of using it, and refers to the field of transport vehicles. A transport vehicle may comprise: a chassis trailer, a lifting device and a hanging device; wherein the chassis trailer may have a carrying area and a hanging area; the lifting device may comprise a lifting drive mechanism and a frame, the lifting drive mechanism may connect the frame to the chassis trailer, the frame may be flippably connected to the chassis trailer, the frame may have a first state and a second state relative to the chassis trailer, the frame in the first state may be laid flat on the carrying area, the frame may be used to carry an equipment body, the frame in the second state may be erected on the chassis trailer and may cause the equipment body to be erected on the hanging area; the hanging device may be provided at the chassis trailer, for hanging the equipment body from the hanging area and transferring it to a predetermined position.

Abstract: Embodiments relate to the field of semiconductors, and provide a semiconductor device and a method for manufacturing the same. The semiconductor device includes: an active pillar including a channel region and a source/drain region arranged on two sides of the channel region; and a gate structure surrounding at least part of the channel region. The channel region includes a peripheral portion and a central portion, the peripheral portion is positioned between the gate structure and the central portion, the source/drain region and the peripheral portion have a first doping type, and the central portion has a second doping type, where the first doping type is one of N-type and P-type, and the second doping type is other one of the N-type and the P-type. At least problems of greater difficulty in turning off existing junctionless field effect transistor and poorer turn-off effect may be solved.

Abstract: A chip loading structure, an analysis device and an analysis system are provided. The chip loading structure includes a loading plate body having therein an accommodating space adapted to accommodate a detection chip; a first hollow area and at least one second hollow area, which penetrate to the accommodating space, are disposed on a first plate surface of the loading plate body, the first hollow area being configured to expose a reaction observation area of the detection chip, the at least one second hollow area being configured to expose at least one reagent port of the detection chip; the loading plate body is further provided with a connection portion which is detachably connectable to a transportation section in an analysis device, the transportation section being configured to transport the loading plate body.

Abstract: An image processing model generation method includes: inputting at least one training sample lesion image into an initial image processing model, the initial image processing model including a classification layer and a marking layer; calling the classification layer; calling the marking layer; obtaining a loss value of the at least one training sample lesion image in the initial image processing model; determining whether the loss value is within a preset range; if not, updating parameters of the initial image processing model, an image processing model with updated parameters being used as an initial image processing model in next training; and repeating above steps until the loss value is within the preset range.

Abstract: A data processing method for a biochip comprises: acquiring a biochip image to be detected; performing binarization processing on the biochip image to obtain a binary image; performing a morphological dilation operation on the binary image in a row direction to obtain a first image, and performing a morphological dilation operation on the binary image in a column direction to obtain a second image; performing connected domain detection on the first image in the row direction, and performing connected domain detection on the second image in the column direction, to determine the number of rows and the number of columns of a sample point array and center position information of each sample point.

Abstract: The present invention discloses a high-resistivity sintered samarium-cobalt magnet and a preparation method thereof. According to the present invention, considering the specialty of sintered samarium-cobalt magnetic powder, fluoride or oxide is firstly prepared into nano-powder using high-energy ball milling, and the samarium-cobalt magnetic powder is prepared separately by rolling ball milling or high-speed jet milling, and then a certain electric field is applied in a fluoride suspension to drive the fluoride nano-powder to evenly cover a surface of the samarium-cobalt magnetic powder. The present invention breaks through the technical bottleneck that fluoride/oxide can improve the resistivity of a samarium-cobalt magnet but result in deterioration of the magnetic properties.

Abstract: Aspects of the subject disclosure may include, for example, obtaining contextual information associated with a user, wherein the user is engaged in an immersive environment using a target user device, and wherein the contextual information comprises user profile data, data regarding a location of the user, data regarding one or more inputs provided by the user, or a combination thereof, receiving data regarding a metaverse object in the immersive environment, determining a relevance of the metaverse object to the user based on the contextual information and the data regarding the metaverse object, responsive to the determining the relevance of the metaverse object to the user, generating a personalized recommendation or review of the metaverse object for the user, and causing the personalized recommendation or review to be provided to the user in the immersive environment for user consumption. Other embodiments are disclosed.

Abstract: Extended reality augmentation of situational navigation (e.g., using a computerized tool) is enabled. For example, a system can comprise: a processor and a memory that stores executable instructions that, when executed by the processor, facilitate performance of operations, comprising: based on a route of a vehicle, determining a navigational instruction to be displayed via an augmented reality interface of the vehicle, and displaying the navigational instruction via the augmented reality interface, wherein displaying the navigational instruction comprises displaying a virtual leading vehicle to be followed by the vehicle.

Abstract: Virtual assistants (VAs) can be managed in interactions with users, other VAs, and devices, including in connection with medical care associated with users. A VA management component (VAMC) can analyze medical information and other information relating to users, including information obtained by a VA(s) from a user(s). Based on the analysis, VAMC can determine a model relating to medical care associated with users. VAMC can determine a proposed action relating to the health or medical care associated with a user based on the model. A VA can present action information relating to the proposed action, or other information relating to health or medical care associated with the user, to the user or a device associated with the user. VAMC can determine drug-drug or drug-food interactions or side effects, and the VA can notify the user regarding the drug-drug or drug-food interactions or side effects.